We are live on
!
Find out more
Loomis, Sayles & Company Portfolio holdings
AUM
$74.3B
1-Year Est. Return
24.01%
This Fund
S&P 500
This Quarter
Est. Return
+9.81%
1 Year Est. Return
+24.01%
3 Year Est. Return
+109.67%
5 Year Est. Return
+145.58%
10 Year Est. Return
+623.12%
AUM
$79.2B
AUM Growth
+$3.07B
(+4%)
Cap. Flow
-$2.3B
Cap. Flow
% of AUM
-2.9%
Top 10 Holdings %
Top 10 Hldgs %
48.93%
Holding
809
New
117
Increased
205
Reduced
335
Closed
91
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Regeneron Pharmaceuticals
REGN
|
+$331M |
| 2 |
Vertex Pharmaceuticals
VRTX
|
+$327M |
| 3 |
NVO
Novo Nordisk
NVO
|
+$319M |
| 4 |
Allison Transmission
ALSN
|
+$195M |
| 5 |
BA.PRA
Boeing Co 6.00% Series A Preferred Stock
BA.PRA
|
+$50M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$853M |
| 2 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$294M |
| 3 |
NVIDIA
NVDA
|
+$266M |
| 4 |
Netflix
NFLX
|
+$190M |
| 5 |
Meta Platforms (Facebook)
META
|
+$175M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.48% |
| 2 | Consumer Discretionary | 18.83% |
| 3 | Communication Services | 18.1% |
| 4 | Healthcare | 11.79% |
| 5 | Financials | 9.65% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
551
Aflac
AFL
$61.5B
| $74K | ﹤0.01% |
716
-149
| -17% | -$16.2K |
|
552
Targa Resources
TRGP
$56.4B
| $74K | ﹤0.01% |
+415
| New | +$74.4K |
|
553
Welltower
WELL
$170B
| $74K | ﹤0.01% |
591
+497
| +529% | +$65.2K |
|
554
3M
MMM
$93.8B
| $73K | ﹤0.01% |
566
-487
| -46% | -$63.9K |
|
555
Realty Income
O
$58.3B
| $73K | ﹤0.01% |
+1,364
| New | +$79.4K |
|
556
Lam Research
LRCX
$386B
| $71K | ﹤0.01% |
979
-4,971
| -84% | -$377K |
|
557
TE Connectivity
TEL
$62.6B
| $71K | ﹤0.01% |
500
+123
| +33% | +$18.3K |
|
558
CSX Corp
CSX
$93.3B
| $70K | ﹤0.01% |
+2,180
| New | +$74.8K |
|
559
Huntington Bancshares
HBAN
$35.3B
| $70K | ﹤0.01% |
+4,296
| New | +$70.6K |
|
560
Honeywell
HON
$77.2B
| $70K | ﹤0.01% |
330
+111
| +51% | +$23.1K |
|
561
Church & Dwight Co
CHD
$24.5B
| $68K | ﹤0.01% |
+652
| New | +$68.8K |
|
562
Capital One
COF
$134B
| $67K | ﹤0.01% |
+375
| New | +$64.9K |
|
|
FISV
563
Fiserv Inc
FISV
$27.6B
| $67K | ﹤0.01% |
324
-84
| -21% | -$17.1K |
|
564
KKR & Co
KKR
$92.3B
| $67K | ﹤0.01% |
+455
| New | +$66.8K |
|
565
Kinder Morgan
KMI
$69.4B
| $67K | ﹤0.01% |
2,434
-951
| -28% | -$24.8K |
|
566
Air Products & Chemicals
APD
$68.1B
| $65K | ﹤0.01% |
224
-110
| -33% | -$34.5K |
|
567
iShares Russell 2000 Value ETF
IWN
$14.5B
| $65K | ﹤0.01% |
398
+226
| +131% | +$38.6K |
|
568
Oneok
OKE
$56B
| $65K | ﹤0.01% |
648
-242
| -27% | -$24.8K |
|
569
PPG Industries
PPG
$25.9B
| $65K | ﹤0.01% |
+543
| New | +$67.9K |
|
570
Travelers Companies
TRV
$78.8B
| $65K | ﹤0.01% |
+271
| New | +$67.7K |
|
571
Constellation Brands
STZ
$22.8B
| $64K | ﹤0.01% |
291
+104
| +56% | +$24.7K |
|
572
Zimmer Biomet
ZBH
$18.4B
| $64K | ﹤0.01% |
+608
| New | +$65.2K |
|
573
American Homes 4 Rent
AMH
$12.3B
| $63K | ﹤0.01% |
1,682
+161
| +11% | +$6.03K |
|
574
Quanta Services
PWR
$100B
| $63K | ﹤0.01% |
+199
| New | +$64K |
|
575
Verisk Analytics
VRSK
$23.7B
| $63K | ﹤0.01% |
+229
| New | +$63.7K |
|
Similar funds
CBU
BC
Loomis, Sayles & Company's Q4 2024 Portfolio in Review
As of Q4 2024, Loomis, Sayles & Company held 809 positions worth $79.2B, up 4% from $76.2B the previous quarter. Its ten largest holdings account for 49% of the portfolio.
Loomis, Sayles & Company's Q4 2024 filing shows 117 new, 205 increased, 335 reduced and 91 closed positions. Its largest new stake was Boeing Co 6.00% Series A Preferred Stock: 886,790 shares worth $157M. The largest sale was Tesla, an estimated $853M.
By sector, the portfolio is most concentrated in Technology at 27% of assets, down from 28% a quarter earlier, followed by Consumer Discretionary and Communication Services.
- Loomis, Sayles & Company's largest Q4 2024 buy was Boeing Co 6.00% Series A Preferred Stock: 886,790 shares worth $157M.
- Loomis, Sayles & Company added most to Regeneron Pharmaceuticals in Q4 2024, an estimated $331M increase.
- Loomis, Sayles & Company's biggest Q4 2024 reduction was Tesla, cutting an estimated $853M.
- Loomis, Sayles & Company fully exited Medpace in Q4 2024, selling an estimated $68.7M.
- Loomis, Sayles & Company's ten largest holdings make up 49% of its $79.2B portfolio in Q4 2024.
- Loomis, Sayles & Company opened 117 new positions and closed 91 in Q4 2024.
- Loomis, Sayles & Company's portfolio value rose 4% quarter-over-quarter to $79.2B.
Based on Loomis, Sayles & Company's 13F filing for Q4 2024, filed 12 Feb 2025.